Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 11-Jul-24 4:15 PM View:  | Savitz Adam Chief Medical Officer | Alto Neuroscience, Inc. (ANRO) | 10-Jul-24 | Purchase | 2,931 | $13.22 | $38,747.80 | 8% 36.92K to 39.85K | |
| 11-Jul-24 4:15 PM View: | Savitz Adam Chief Medical Officer | Alto Neuroscience, Inc. (ANRO) | 09-Jul-24 | Purchase | 12,069 | $12.60 | $152,085.00 | 49% 24.85K to 36.92K | |
| 01-Apr-24 4:15 PM View: | Smith Nicholas Conrad CHIEF FINANCIAL OFFICER | Alto Neuroscience, Inc. (ANRO) | 28-Mar-24 | Purchase | 6,150 | $16.36 | $100,628.00 | 30% 20.72K to 26.87K | |
| 05-Mar-24 6:00 PM View: | Etkin Amit President and CEO Director | Alto Neuroscience, Inc. (ANRO) | 01-Mar-24 | Grant | 34,711 | -- | -- | 3% 1.21M to 1.24M | |
| 05-Mar-24 6:00 PM View: | Smith Nicholas Conrad CHIEF FINANCIAL OFFICER | Alto Neuroscience, Inc. (ANRO) | 01-Mar-24 | Grant | 19,153 | -- | -- | 1225% 1.56K to 20.72K | |
| 07-Feb-24 4:38 PM View: | Savitz Adam Chief Medical Officer | Alto Neuroscience, Inc. (ANRO) | 06-Feb-24 | Conversion | 7,851 | -- | -- | 100% 0 to 7.85K | |
| 08-Feb-24 4:32 PM View: | Falcon Edge Capital, Lp 10% Owner | Alto Neuroscience, Inc. (ANRO) | 06-Feb-24 | Conversion | 3,107,760 | -- | -- | 100% 0 to 3.11M | |
| 07-Feb-24 4:36 PM View: | Etkin Amit President and CEO Director | Alto Neuroscience, Inc. (ANRO) | 06-Feb-24 | Purchase | 3,125 | $16.00 | $50,000.00 | < 1% 1.2M to 1.21M | |
| 08-Feb-24 4:32 PM View: | Falcon Edge Capital, Lp 10% Owner | Alto Neuroscience, Inc. (ANRO) | 06-Feb-24 | Purchase | 600,000 | $16.00 | $9,600,000.00 | 19% 3.11M to 3.71M | |
| 07-Feb-24 4:35 PM View: | Chen Po Yu (jeff) Director | Alto Neuroscience, Inc. (ANRO) | 06-Feb-24 | Conversion | 47,709 | -- | -- | 100% 0 to 47.71K | |
| 07-Feb-24 4:39 PM View: | Cox Christopher Nixon Director | Alto Neuroscience, Inc. (ANRO) | 06-Feb-24 | Conversion | 715,653 | -- | -- | 100% 0 to 715.65K | |
| 06-Mar-24 9:15 AM View: | Apeiron Investment Group Ltd. | Alto Neuroscience, Inc. (ANRO) | 06-Feb-24 | Conversion | 251,881 | -- | -- | 100% 0 to 251.88K | |
| 07-Feb-24 4:38 PM View: | Savitz Adam Chief Medical Officer | Alto Neuroscience, Inc. (ANRO) | 06-Feb-24 | Purchase | 17,000 | $16.00 | $272,000.00 | 217% 7.85K to 24.85K | |
| 07-Feb-24 4:36 PM View: | Etkin Amit President and CEO Director | Alto Neuroscience, Inc. (ANRO) | 06-Feb-24 | Conversion | 11,777 | -- | -- | < 1% 1.19M to 1.2M | |
| 07-Feb-24 4:41 PM View: | York Gwill Director | Alto Neuroscience, Inc. (ANRO) | 06-Feb-24 | Conversion | 23,917 | -- | -- | 100% 0 to 23.92K | |
| 06-Mar-24 9:15 AM View: | Apeiron Investment Group Ltd. | Alto Neuroscience, Inc. (ANRO) | 06-Feb-24 | Conversion | 674,658 | -- | -- | 268% 251.88K to 926.54K | |
| 07-Feb-24 4:40 PM View: | Smith Nicholas Conrad CHIEF FINANCIAL OFFICER | Alto Neuroscience, Inc. (ANRO) | 06-Feb-24 | Purchase | 1,563 | $16.00 | $25,008.00 | 100% 0 to 1.56K |
